Lower middle income | Immunization, measles (% of children ages 12-23 months)

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Lower middle income
Records
63
Source
Lower middle income | Immunization, measles (% of children ages 12-23 months)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980 4.01521054
1981 5.26454524
1982 6.68313104
1983 8.99891649
1984 13.21944882
1985 19.37349372
1986 27.25156202
1987 35.87909145
1988 44.58893687
1989 54.02270919
1990 62.34141124
1991 56.66627131
1992 60.87755013
1993 64.54015567
1994 68.75424952
1995 70.88784825
1996 67.92243953
1997 63.38560167
1998 62.70624723
1999 63.35387009
2000 63.57430015
2001 64.53707147
2002 64.03962635
2003 66.62429097
2004 69.36928259
2005 71.43108956
2006 72.05150228
2007 72.7066199
2008 74.55313902
2009 78.5274726
2010 79.52313529
2011 79.83853855
2012 79.32627212
2013 79.96568553
2014 80.71405901
2015 81.45272511
2016 82.25197823
2017 83.49872574
2018 84.91764845
2019 85.65988439
2020 83.11220004
2021 81.06538224
2022 84.31928637

Lower middle income | Immunization, measles (% of children ages 12-23 months)

Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine. Development relevance: Immunization is one of the most cost-effective public health interventions, and ??is an essential component for reducing under-five mortality. Immunization coverage estimates are used to monitor coverage of immunization services and to guide disease eradication and elimination efforts. Limitations and exceptions: In many developing countries a lack of precise information on the size of the cohort of one-year-old children makes immunization coverage difficult to estimate from program statistics. Statistical concept and methodology: Governments in developing countries usually finance immunization against measles and diphtheria, pertussis (whooping cough), and tetanus (DTP) as part of the basic public health package. The data shown here are based on an assessment of national immunization coverage rates by the WHO and UNICEF. The assessment considered both administrative data from service providers and household survey data on children's immunization histories. Based on the data available, consideration of potential biases, and contributions of local experts, the most likely true level of immunization coverage was determined for each year. Notes on regional and global aggregates: When the vaccine is not introduced in a national immunization schedule, the missing value is assumed zero (or close to zero) in the relevant groups' averages.
Publisher
The World Bank
Origin
Lower middle income
Records
63
Source